India is building an open database that would be soon accessible to global drug regulators and stakeholders following the issue of fake drugs from the country. The barcoding system on medicines has earlier established by the government to understand the source of the drugs exported. It will be started as a pilot project by adding few selected exporters data, and experts will make a track and trace system within four months. Medicines worth $15.2 billion has been exported last year, 5 % more than the year before. READ ALSO: Stunning First Visit PM Modi in the US.

“Medical exporters have come forward to upload the data in the central server. Sun Pharma, Wockhardt and Unichem are amongst them and talks are going on with Dr Reddy’s Laboratories, Mylan Labs, Sandoz and Aurobindo Pharma to participate in the pilot project” said PV Appaji, director general of Indian Pharmaceuticals Export Promotion Council. The expert group comprises of some industry tops, including Appaji as member secretary, Sudhanshu Pandey – the commerce ministry’s joint secretary, Sudhansh Pant – pharmaceuticals department’s joint secretary and the Drug Controller General of India (DCGI). The president of Indian Drug Manufacturers, Veeramani said “India is the first country to implement barcode system in the world. The industry players seek clarity on the technologies for uploading their manufacturing data and security measures”

The Economic Times

Other News

  • Medical Devices

India Medical Device Pricing Strategy: Ensuring Growth & Affordability

India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]

Read More

Imports of High-Value Medical Equipment

High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]

Read More

SEC Committee: Pioneering Medical Approvals

New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]

Read More
  • ErlySign's Oral Cancer Detection

ErlySign Oral Cancer Detection Technology Gets CDSCO Nod

ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]

Read More

Additional Steps Announced by FDA to Modernize Clinical Trials

The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]

Read More

Accreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA 

This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]

Read More

BSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]

Read More

TUV SUD Inspects IVD Medical Devices’ Cyber Security

The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]

Read More